Author(s): Raksha Sharma, Mukesh Kumar Kumawat, Gyanendra Kumar Sharma

Email(s): phmukesh@gmail.com

DOI: 10.52711/0974-360X.2022.00770   

Address: Raksha Sharma1, Mukesh Kumar Kumawat2*, Gyanendra Kumar Sharma1
1Department of Pharmaceutical Chemistry, Rajiv Academy for Pharmacy, National Highway No.-2, Mathura - Delhi Road, Mathura - 281001, Uttar Pradesh, India.
2School of Pharmaceutical Sciences, Apeejay Stya University, Sohna - Palwal Road, Sohna, Gurugram - 122102, Haryana, India.
*Corresponding Author

Published In:   Volume - 15,      Issue - 10,     Year - 2022


ABSTRACT:
In the present study, 50 derivatives of novel 4-aminoquinoline-monastrol hybrids were designed and docking studies were performed using Autodock 4. In the docking experiment, the hybrid compounds were docked in the binding pocket of pfLDH (plasmodium falciparum lactate dehydrogenase) (PDB ID- 1CET). The docking interactions of 4-aminoquinoline-monastrol compounds with ALA98, the active site of target protein were good. Compound 19 showed H-bonding interactions with ALA98, the active site of pfLDH and the compound 17, 23 and 40 showed alkyl bonding interactions with ALA98 of target protein. These compounds were selected on the basis of lowest binding energies (-10.40 to -12.47Kcal/mol). According to our study, these hybrid compounds may be a useful pharmacophore against malaria. On the basis of in-silico studies and predicted pharmacokinetic properties and druglikeness, it is stated that, these hybrid molecules have potential to become potent drug against malaria.


Cite this article:
Raksha Sharma, Mukesh Kumar Kumawat, Gyanendra Kumar Sharma. In-silico Design and Molecular Docking Studies of some novel 4-Aminoquinoline-Monastrol hybrids for their Antimalarial Activity. Research Journal of Pharmacy and Technology 2022; 15(10):4589-3. doi: 10.52711/0974-360X.2022.00770

Cite(Electronic):
Raksha Sharma, Mukesh Kumar Kumawat, Gyanendra Kumar Sharma. In-silico Design and Molecular Docking Studies of some novel 4-Aminoquinoline-Monastrol hybrids for their Antimalarial Activity. Research Journal of Pharmacy and Technology 2022; 15(10):4589-3. doi: 10.52711/0974-360X.2022.00770   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-10-43


REFERENCES:
1.    Tuteja R. Malaria-an overview. FEBS Journal. 2007; 274, 4670-4679.. (doi:10.1111/j.1742-4658.2007.05997.x)
2.    World Health Organization Malaria Report 2020, https://www.who.int Acessed on 20.07.2020.
3.    Greenwood B. Mutabingwa T. Malaria in 2002. Nature. 2002; VOL 415, 670-672.
4.    Teixeria C. Vale N. Perez B. Gomes A. Gomes JRB. Gomes P. “Recycling” Classical Drugs for Malaria. Chem. Rev. 2014. 2014; 114, 11164-11220. (doi: dx.doi.org/10.1021/cr500123g)
5.    Plebanski M. Hill AVS. The immunology of malaria infection. Current Opinion in Immunology 2000. 2002; 12, 437–441.
6.    Agarwal D. Gupta RD. Awasthi SA. Antimalarial hybrid molecules: a close reality or a distant dream?. Antimicrob. Agents Chemother. 2017; 1-29. (doi:10.1128/AAC.00249-17).
7.    Meuiner B. Hybrid molecules with a Dual Mode of Action: Dream or Reality?. Accounts of Chemical Research. 2007; Vol. 41, No. 1, 69-77.
8.    Bhagat S. Arfeen M. Das G. Ramkumar M. Khan SI. Tekwani BI. Bharatam PV. Design, synthesis and biological evaluation of 4-aminoquinoline-guanylthiourea derivatives as antimalarial agents. Bioorganic Chemistry 91 (2019). 2019; 103094, 1-8. (https://doi.org/10.1016/j.bioorg.2019.103094)
9.    Sahu S. Ghosh SK. Kalita J. Dutta M. Bhat HR. Design, synthesis and antimalarial screening of some hybrid 4-aminoquinoline-triazine derivatives pf-DHFR-TS. Experimental Parasitology (2016). 2016; 1-8. (doi: 10.1016/j.exppara.2016.01.010)
10.    Bhat HR. Singh UP. Thakur A. Ghosh SK. Gogoi K., Prakash A. Singh RK. Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives, Experimental Parasitology(2015). (http://dx.doi.org/10.1016/j.exppara.2015.06.016)
11.    Kumar D. Khan SI. Tekwani BL. Ponnan P. Rawat DS. 4-Aminoquinoline-pyrimidine hybrids: Synthesis, antimalarial activity, heme binding and docking studies, European Journal of Medicinal Chemistry 89 (2015). 2014; 490-502. (http://dx.doi.org/10.1016/j.ejmech.2014.10.061)
12.    Kumawat MK. Dipak C. Molecular docking studies of some novel hybrid tetraoxaquines and dispirotetraoxanes as antimalarial agents, IJPSR, 2016; Vol. 7(3): 1353-1364. (doi: 10.3329/bjp.v10i4.24532)
13.    Halgren TA. Merck molecular force field. I. Basis, form, scope, parametrization, and performance of MMFF94. Journal of Computational Chemistry, 1998; 17 (5-6): 490-519.
14.    Kumawat MK. Chetia D. Molecular Docking Studies of Some Novel 1,2,4,5-Tetraoxane Derivatives as Antimalarial Agents, World Journal of Pharmacy and Pharmaceutical Sciences. 2015; Vol 4, Issue 10, 890-908.  

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available